Lanreotide Subcutaneous and Methyldopa and Hydrochlorothiazide
Determining the interaction of Lanreotide Subcutaneous and Methyldopa and Hydrochlorothiazide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lanreotide
Brand name: Somatuline Depot
Synonyms: Lanreotide
Generic Name: hydrochlorothiazide / methyldopa
Brand name: Aldoril 15, Aldoril 25, Aldoril D30, Aldoril D50
Synonyms: Hydrochlorothiazide and methyldopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lanreotide Subcutaneous-Methyldopa Oral, Intravenous
- Lanreotide Subcutaneous-Methyldopa Tablets
- Lanreotide Subcutaneous-Methyldopate
- Lanreotide Subcutaneous-Methyldopate hydrochloride
- Lanreotide Subcutaneous-Methylene Blue
- Lanreotide Subcutaneous-Methylene blue injection
- Methyldopa and Hydrochlorothiazide-Lansoprazole
- Methyldopa and Hydrochlorothiazide-Lansoprazole Delayed-Release Capsules
- Methyldopa and Hydrochlorothiazide-Lansoprazole Orally Disintegrating Tablets
- Methyldopa and Hydrochlorothiazide-Lansoprazole, Amoxicillin, and Clarithromycin
- Methyldopa and Hydrochlorothiazide-Lanthanum
- Methyldopa and Hydrochlorothiazide-Lanthanum carbonate